BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Schmidt AF, Finan C, Gordillo-Marañón M, Asselbergs FW, Freitag DF, Patel RS, Tyl B, Chopade S, Faraway R, Zwierzyna M, Hingorani AD. Genetic drug target validation using Mendelian randomisation. Nat Commun 2020;11:3255. [PMID: 32591531 DOI: 10.1038/s41467-020-16969-0] [Cited by in Crossref: 23] [Cited by in F6Publishing: 17] [Article Influence: 11.5] [Reference Citation Analysis]
Number Citing Articles
1 Rosoff DB, Bell AS, Jung J, Wagner J, Mavromatis LA, Lohoff FW. Mendelian Randomization Study of PCSK9 and HMG-CoA Reductase Inhibition and Cognitive Function. J Am Coll Cardiol 2022;80:653-62. [PMID: 35953131 DOI: 10.1016/j.jacc.2022.05.041] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Lu T, Forgetta V, Greenwood CM, Zhou S, Richards JB. Circulating Proteins Influencing Psychiatric Disease: A Mendelian Randomization Study. Biological Psychiatry 2022. [DOI: 10.1016/j.biopsych.2022.08.015] [Reference Citation Analysis]
3 Taschler B, Smith SM, Nichols TE. Causal inference on neuroimaging data with Mendelian randomisation. Neuroimage 2022;258:119385. [PMID: 35714886 DOI: 10.1016/j.neuroimage.2022.119385] [Reference Citation Analysis]
4 Batool F, Patel A, Gill D, Burgess S. Disentangling the effects of traits with shared clustered genetic predictors using multivariable Mendelian randomization. Genet Epidemiol 2022. [PMID: 35638254 DOI: 10.1002/gepi.22462] [Reference Citation Analysis]
5 Zuber V, Grinberg NF, Gill D, Manipur I, Slob EAW, Patel A, Wallace C, Burgess S. Combining evidence from Mendelian randomization and colocalization: Review and comparison of approaches. Am J Hum Genet 2022;109:767-82. [PMID: 35452592 DOI: 10.1016/j.ajhg.2022.04.001] [Cited by in Crossref: 9] [Article Influence: 9.0] [Reference Citation Analysis]
6 Wang Q, Richardson TG, Sanderson E, Tudball MJ, Ala-Korpela M, Davey Smith G, Holmes MV. A phenome-wide bidirectional Mendelian randomization analysis of atrial fibrillation. Int J Epidemiol 2022:dyac041. [PMID: 35292824 DOI: 10.1093/ije/dyac041] [Reference Citation Analysis]
7 Kang X, Jiao T, Wang H, Pernow J, Wirdefeldt K. Mendelian randomization study on the causal effects of tumor necrosis factor inhibition on coronary artery disease and ischemic stroke among the general population. EBioMedicine 2022;76:103824. [PMID: 35074627 DOI: 10.1016/j.ebiom.2022.103824] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Bouras E, Karhunen V, Gill D, Huang J, Haycock PC, Gunter MJ, Johansson M, Brennan P, Key T, Lewis SJ, Martin RM, Murphy N, Platz EA, Travis R, Yarmolinsky J, Zuber V, Martin P, Katsoulis M, Freisling H, Nøst TH, Schulze MB, Dossus L, Hung RJ, Amos CI, Ahola-Olli A, Palaniswamy S, Männikkö M, Auvinen J, Herzig KH, Keinänen-Kiukaanniemi S, Lehtimäki T, Salomaa V, Raitakari O, Salmi M, Jalkanen S, Jarvelin MR, Dehghan A, Tsilidis KK; PRACTICAL consortium. Circulating inflammatory cytokines and risk of five cancers: a Mendelian randomization analysis. BMC Med 2022;20:3. [PMID: 35012533 DOI: 10.1186/s12916-021-02193-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
9 Storm CS, Kia DA, Almramhi MM, Bandres-Ciga S, Finan C, Hingorani AD, Wood NW; International Parkinson’s Disease Genomics Consortium (IPDGC). Finding genetically-supported drug targets for Parkinson's disease using Mendelian randomization of the druggable genome. Nat Commun 2021;12:7342. [PMID: 34930919 DOI: 10.1038/s41467-021-26280-1] [Reference Citation Analysis]
10 Davitte JM, Stott-Miller M, Ehm MG, Cunnington MC, Reynolds RF. Integration of Real-World Data and Genetics to Support Target Identification and Validation. Clin Pharmacol Ther 2022;111:63-76. [PMID: 34818443 DOI: 10.1002/cpt.2477] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Liu L, Sheng C, Lyu Z, Dai H, Chen K. Association Between Genetically Proxied Lipid-Lowering Drug Targets and Renal Cell Carcinoma: A Mendelian Randomization Study. Front Nutr 2021;8:755834. [PMID: 34712689 DOI: 10.3389/fnut.2021.755834] [Reference Citation Analysis]
12 Skrivankova VW, Richmond RC, Woolf BAR, Davies NM, Swanson SA, VanderWeele TJ, Timpson NJ, Higgins JPT, Dimou N, Langenberg C, Loder EW, Golub RM, Egger M, Davey Smith G, Richards JB. Strengthening the reporting of observational studies in epidemiology using mendelian randomisation (STROBE-MR): explanation and elaboration. BMJ 2021;375:n2233. [PMID: 34702754 DOI: 10.1136/bmj.n2233] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Gordillo-Marañón M, Zwierzyna M, Charoen P, Drenos F, Chopade S, Shah T, Engmann J, Chaturvedi N, Papacosta O, Wannamethee G, Wong A, Sofat R, Kivimaki M, Price JF, Hughes AD, Gaunt TR, Lawlor DA, Gaulton A, Hingorani AD, Schmidt AF, Finan C. Validation of lipid-related therapeutic targets for coronary heart disease prevention using human genetics. Nat Commun 2021;12:6120. [PMID: 34675202 DOI: 10.1038/s41467-021-25731-z] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
14 Schmidt AF, Hunt NB, Gordillo-Marañón M, Charoen P, Drenos F, Kivimaki M, Lawlor DA, Giambartolomei C, Papacosta O, Chaturvedi N, Bis JC, O'Donnell CJ, Wannamethee G, Wong A, Price JF, Hughes AD, Gaunt TR, Franceschini N, Mook-Kanamori DO, Zwierzyna M, Sofat R, Hingorani AD, Finan C. Cholesteryl ester transfer protein (CETP) as a drug target for cardiovascular disease. Nat Commun 2021;12:5640. [PMID: 34561430 DOI: 10.1038/s41467-021-25703-3] [Reference Citation Analysis]
15 Acosta JN, Szejko N, Falcone GJ. Mendelian Randomization in Stroke: A Powerful Approach to Causal Inference and Drug Target Validation. Front Genet 2021;12:683082. [PMID: 34456968 DOI: 10.3389/fgene.2021.683082] [Reference Citation Analysis]
16 Ala-Korpela M, Zhao S, Järvelin MR, Mäkinen VP, Ohukainen P. Apt interpretation of comprehensive lipoprotein data in large-scale epidemiology: disclosure of fundamental structural and metabolic relationships. Int J Epidemiol 2021:dyab156. [PMID: 34405869 DOI: 10.1093/ije/dyab156] [Reference Citation Analysis]
17 Georgakis MK, Gill D. Mendelian Randomization Studies in Stroke: Exploration of Risk Factors and Drug Targets With Human Genetic Data. Stroke 2021;52:2992-3003. [PMID: 34399585 DOI: 10.1161/STROKEAHA.120.032617] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Yang J, Fan Y, Yan B, Zhao B, Qian L, Gao F, Ma Q, Yang L, Wang W, Bai L, Zhu F, Ma X. Mendelian randomization analyses reveal novel drug targets for anorexia nervosa. Prog Neuropsychopharmacol Biol Psychiatry 2021;112:110427. [PMID: 34389437 DOI: 10.1016/j.pnpbp.2021.110427] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Reay WR, Cairns MJ. Advancing the use of genome-wide association studies for drug repurposing. Nat Rev Genet 2021. [PMID: 34302145 DOI: 10.1038/s41576-021-00387-z] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
20 Norouzi-Barough L, Bayat A. Validation strategies for identifying drug targets in dermal fibrotic disorders. Drug Discov Today 2021:S1359-6446(21)00285-3. [PMID: 34229083 DOI: 10.1016/j.drudis.2021.06.014] [Reference Citation Analysis]
21 Levin MG, Zuber V, Walker VM, Klarin D, Lynch J, Malik R, Aday AW, Bottolo L, Pradhan AD, Dichgans M, Chang KM, Rader DJ, Tsao PS, Voight BF, Gill D, Burgess S, Damrauer SM. Prioritizing the Role of Major Lipoproteins and Subfractions as Risk Factors for Peripheral Artery Disease. Circulation 2021;144:353-64. [PMID: 34139859 DOI: 10.1161/CIRCULATIONAHA.121.053797] [Reference Citation Analysis]
22 Holmes MV, Richardson TG, Ference BA, Davies NM, Davey Smith G. Integrating genomics with biomarkers and therapeutic targets to invigorate cardiovascular drug development. Nat Rev Cardiol 2021;18:435-53. [PMID: 33707768 DOI: 10.1038/s41569-020-00493-1] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 8.0] [Reference Citation Analysis]
23 Gill D, Georgakis MK, Walker VM, Schmidt AF, Gkatzionis A, Freitag DF, Finan C, Hingorani AD, Howson JMM, Burgess S, Swerdlow DI, Davey Smith G, Holmes MV, Dichgans M, Scott RA, Zheng J, Psaty BM, Davies NM. Mendelian randomization for studying the effects of perturbing drug targets. Wellcome Open Res 2021;6:16. [PMID: 33644404 DOI: 10.12688/wellcomeopenres.16544.2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
24 Molendijk J, Parker BL. Proteome-wide Systems Genetics to Identify Functional Regulators of Complex Traits. Cell Syst 2021;12:5-22. [PMID: 33476553 DOI: 10.1016/j.cels.2020.10.005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
25 Xu S, Wang T, Liu G, Cao Z, Frank LA, Jiang S, Zhang C, Li Z, Krasitskaya VV, Li Q, Sha Y, Zhang X, Liu H, Wang J. Analysis of interactions between proteins and small-molecule drugs by a biosensor based on a graphene field-effect transistor. Sensors and Actuators B: Chemical 2021;326:128991. [DOI: 10.1016/j.snb.2020.128991] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 5.0] [Reference Citation Analysis]
26 Loos RJF. 15 years of genome-wide association studies and no signs of slowing down. Nat Commun 2020;11:5900. [PMID: 33214558 DOI: 10.1038/s41467-020-19653-5] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 5.5] [Reference Citation Analysis]
27 Trajanoska K, Rivadeneira F. Genomic Medicine: Lessons Learned From Monogenic and Complex Bone Disorders. Front Endocrinol (Lausanne) 2020;11:556610. [PMID: 33162933 DOI: 10.3389/fendo.2020.556610] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]